
|Slideshows|July 30, 2020
- MHE July 2020
- Volume 30
- Issue 7
MHE 2020 Annual Pharmacy Survey pt. 2
Author(s)MHE Staff
Listen
0:00 / 0:00
As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.
Advertisement
Overall, the responses paint a picture of the pandemic having a major impact, which is not surprising, and reveal some optimism; for example, 78% of the respondents expect to see at least limited use of a COVID-19 vaccine by the first quarter of 2021.
Articles in this issue
about 6 years ago
Upping the Cardiovascular Health Gameabout 6 years ago
MHE 2020 Annual Pharmacy Survey pt. 3about 6 years ago
New Drugs Take Aim at Autoimmune Diseasesabout 6 years ago
Is the Biosimilars Waiting Game Finally Over?about 6 years ago
Racial Disparities in Cancer Enter the Spotlightabout 6 years ago
MHE 2020 Annual Pharmacy Surveyabout 6 years ago
Opinion: The Future of Pharmacy Care Services, Post-Pandemicabout 6 years ago
Has the C-Suite Gotten Too Big?about 6 years ago
Protecting the Integrity of EHR Clinical Decision Support ToolsAdvertisement
Related to this article

A review of 57 studies found music eases pain through positive emotion, control and moving in time with the beat, according to recent research out of Drexel University.

UC San Diego researchers found that early-onset metabolic dysfunction-associated steatotic liver disease cirrhosis was linked to higher genetic risk and Type 2 diabetes prevalence.

Behavior-informed care applies behavioral science principles to personalize support, including positive reinforcement and timely prompts.

Elevated levels of immunoglobulin G (IgG) drive “inflammaging” processes that take a toll on skin tissue as people age, according to research results reported by Japanese researchers. Reducing IgG may mitigate the loss of collagen and elastin.

Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.

Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.

ProAct Chief Operating Offier Deborah Dempsey says plan sponsors still lack the data and visibility to know whether they were shorted on a 340B claim.
Advertisement
Advertisement



